REQUEST A DEMO
Total
USD $0.00
Search more companies

Medicina Metabolica y de Crecimiento Iemyr S.A. (Ecuador)

Main Activities: Medical and Diagnostic Laboratories
Full name: Medicina Metabolica y de Crecimiento Iemyr S.A. Profile Updated: April 15, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Medicina Metabolica y de Crecimiento Iemyr S.A. is based in Ecuador, with the head office in Quito. It operates in the Medical and Diagnostic Laboratories sector. The company was established on November 14, 2007. The total number of employees is currently 1 (2023). From the latest financial highlights, Medicina Metabolica y de Crecimiento Iemyr S.A. reported a net sales revenue increase of 217.07% in 2023. There was a total negative growth of 9.62% in Medicina Metabolica y de Crecimiento Iemyr S.A.’s total assets over the same period. The enterprise’s net profit margin increased by 380.91% in 2023.

Headquarters
Coruna N26-191
Quito; Pichincha;

Contact Details: Purchase the Medicina Metabolica y de Crecimiento Iemyr S.A. report to view the information.

Basic Information
Total Employees:
Purchase the Medicina Metabolica y de Crecimiento Iemyr S.A. report to view the information.
Outstanding Shares:
Purchase the Medicina Metabolica y de Crecimiento Iemyr S.A. report to view the information.
Registered Capital:
Purchase the Medicina Metabolica y de Crecimiento Iemyr S.A. report to view the information.
Incorporation Date:
November 14, 2007
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
General Manager
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Medicina Metabolica y de Crecimiento Iemyr S.A. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
217.07%
Total operating revenue
202.04%
Operating profit (EBIT)
96.35%
EBITDA
N/A
Net Profit (Loss) for the Period
95.02%
Total assets
-9.62%
Total equity
-12.2%
Operating Profit Margin (ROS)
380.65%
Net Profit Margin
380.91%
Return on Equity (ROE)
13.48%
Debt to Equity Ratio
-0.02%
Quick Ratio
-366.19%
Cash Ratio
-366.23%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?